Country Profile
Nicaragua is an emerging destination for Indian pharmaceutical exports — $27.1M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 67% of shipments, with vaccines contributing $5.67M. The compound annual growth rate since FY2015 stands at 9.3%.
No recorded pharmaceutical sector investment transactions from Indian companies to Nicaragua in the RBI overseas direct investment dataset (2011–2026).